IPO launch on Euronext Paris

AFFLUENT MEDICAL launches its IPO on the regulated Euronext Paris market

• Capital increase of approximately €33.0 million, which may be increased to approximately €43.6 million in the event of the full exercise of the extension and over-allotment clause

• Subscription commitments received in the amount of €20 million

• Indicative price range applicable to the Offering: between €7.40 and €9.80 per share

• Subscription period: from 27 May 2021 to 8 June 2021, inclusive, for the French Public Offer (5:00 p.m. for subscriptions over the counter and 8:00 p.m. for internet subscriptions) and until noon on 9 June 2021 for the international offering